Sugar · Founded 1956 · www.godavaribiorefineries.com · BSE 544279 · NSE GODAVARIB · ISIN INE497S01012
No Notes Added Yet
Business
Godavari Biorefineries Ltd. (GBL) is an integrated bio-refinery company in India, primarily involved in the processing of sugarcane. Its core business extends beyond conventional sugar production to leverage various by-products for diversified revenue streams. This includes the manufacturing of crystal sugar, ethanol (from molasses), co-generation of power (from bagasse), and the production of specialty chemicals such as industrial alcohol, rectified spirit, extra neutral alcohol, and other value-added chemicals derived from biomass. The "biorefineries" aspect signifies its focus on converting renewable resources into various fuels, chemicals, and sugar, thereby maximizing resource utilization and reducing dependence solely on sugar commodity prices. The company generates revenue through the sale of these various products to industrial, commercial, and consumer markets.
Revenue Mix
While specific revenue percentages are not available, Godavari Biorefineries typically operates across the following key segments:
Sugar: Production and sale of crystal sugar for domestic consumption and export.
Biofuels (Ethanol): Manufacturing and sale of ethanol, primarily supplied for blending with petrol as per government mandates.
Power Co-generation: Generation and sale of electricity using bagasse (a fibrous residue of sugarcane) as fuel.
Specialty Chemicals: Production of various alcohol-based chemicals, rectified spirits, and other derivatives used in industries such as pharmaceuticals, distilleries, and as industrial solvents.
This integrated model aims to mitigate risks associated with the cyclical nature of the sugar industry by diversifying its product portfolio.
Industry
The Indian sugar industry is highly regulated, cyclical, and significantly influenced by monsoon patterns and sugarcane cultivation. It is characterized by numerous players, many of whom are integrated sugar mills. Godavari Biorefineries positions itself as an integrated bio-refinery, distinguishing itself by moving beyond traditional sugar production into higher-value and diversified products like ethanol and specialty chemicals. This diversification offers a degree of insulation from the inherent volatility of sugar prices and allows the company to capitalize on the growing demand for biofuels and biochemicals. Its positioning is among the established medium-to-large scale players within India's sugar and bio-products sector, with a strategic emphasis on value addition and sustainability.
MOAT
Integrated Operations and Diversification: By efficiently converting sugarcane into multiple products (sugar, ethanol, power, chemicals), GBL maximizes value extraction from its raw material. This diversification spreads business risk across various revenue streams and provides operational flexibility, potentially leading to better margins compared to standalone sugar mills.
Scale and Operational Efficiency: Significant crushing capacity and multiple manufacturing units can lead to economies of scale in raw material procurement, processing, and distribution.
Backward Integration and Farmer Relationships: Strong relationships with local farmers for sugarcane procurement ensure a relatively consistent and reliable supply of raw materials, which is critical in an agro-based industry.
Product Expertise in Specialty Chemicals: Developing capabilities and market access for specialty chemicals allows the company to move into higher-margin product categories compared to bulk commodities.
Growth Drivers
Government Ethanol Blending Program (EBP): India's aggressive targets for ethanol blending with petrol (E20 by 2025) provide a strong, sustained, and policy-backed demand driver for ethanol producers like GBL.
Rising Domestic Sugar Consumption: Steady population growth and increasing disposable incomes in India contribute to consistent domestic demand for sugar.
Increased Biofuel Demand: A global and national push towards renewable energy and cleaner fuels supports the demand for ethanol and other bio-products.
Value-Added Product Expansion: Further development and expansion into higher-margin specialty chemicals and derivatives can enhance profitability and diversify the revenue base.
Operational Efficiency and Capacity Expansion: Investments in modernizing facilities, optimizing processes, and expanding crushing/distillery capacities can lead to higher output and improved cost structures.
Risks
Government Regulation & Policy Changes: The sugar industry is heavily regulated in India (e.g., cane pricing, ethanol pricing, export/import policies). Adverse or frequent policy changes can significantly impact profitability and business stability.
Climatic & Agricultural Risks: High dependence on monsoon patterns and sugarcane yield makes the company vulnerable to droughts, floods, or diseases, leading to raw material shortages and price volatility.
Commodity Price Volatility: Fluctuations in global and domestic prices of sugar, ethanol, and co-generated power can directly affect revenue and profit margins.
Raw Material Availability & Pricing: Ensuring adequate and timely supply of sugarcane at competitive prices remains a continuous challenge.
Environmental Regulations: Stricter environmental norms for distilleries, sugar mills, and chemical plants can increase compliance costs and potentially impact operations.
Debt Levels: The capital-intensive nature of the sugar and biorefinery business often results in higher debt levels, making the company susceptible to interest rate fluctuations and financing costs.
Management & Ownership
Godavari Biorefineries Ltd. is likely promoted and controlled by an experienced Indian business family, which is a common structure in the Indian sugar and agro-processing sector. The management team typically comprises seasoned professionals with deep industry knowledge in sugar, chemicals, and energy sectors. Their expertise is crucial for navigating the complex regulatory environment, managing agricultural supply chains, and driving diversification efforts. Ownership is usually concentrated with the promoter group, indicating a long-term strategic vision, with a portion held by public and institutional investors.
Outlook
Godavari Biorefineries is well-positioned to capitalize on India's steady demand for sugar and the robust government impetus for ethanol blending. Its integrated bio-refinery model, diversifying revenue across sugar, ethanol, power, and specialty chemicals, provides a crucial hedge against the inherent cyclicality and price volatility of the sugar commodity market. The ambitious ethanol blending targets represent a significant and stable growth avenue for the company. However, the business faces substantial risks including the vagaries of monsoon and sugarcane production, unpredictable government policies impacting cane and product prices, and the cyclical nature of commodity markets. Sustained profitability and growth will depend on the company's ability to maintain operational efficiencies, secure consistent raw material supply, effectively manage its diversified portfolio, and adapt to evolving regulatory landscapes.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 398 | 615 | 523 | 321 | 447 | 580 | 533 | 431 | 460 | 564 |
| Other Income | 2 | 11 | 3 | 1 | 4 | 9 | 1 | 4 | 2 | 6 |
| Total Income | 400 | 626 | 525 | 322 | 451 | 589 | 534 | 434 | 462 | 570 |
| Total Expenditure | 353 | 501 | 535 | 354 | 411 | 467 | 527 | 439 | 417 | 478 |
| Operating Profit | 47 | 124 | -9 | -32 | 40 | 122 | 6 | -4 | 45 | 92 |
| Interest | 18 | 20 | 20 | 20 | 19 | 13 | 15 | 12 | 10 | 11 |
| Depreciation | 16 | 14 | 13 | 12 | 12 | 13 | 13 | 14 | 14 | 14 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -27 | -8 | 3 |
| Profit Before Tax | 13 | 91 | -42 | -64 | 8 | 96 | -22 | -57 | 13 | 70 |
| Provision for Tax | -26 | 26 | -16 | 11 | 3 | 24 | -6 | -15 | 5 | 17 |
| Profit After Tax | 38 | 65 | -26 | -75 | 6 | 72 | -16 | -42 | 8 | 53 |
| Adjustments | 0 | -0 | 0 | -0 | 0 | 0 | -0 | 0 | 0 | 0 |
| Profit After Adjustments | 38 | 65 | -26 | -75 | 6 | 72 | -16 | -42 | 8 | 53 |
| Adjusted Earnings Per Share | 9.2 | 15.5 | -6.2 | -17.9 | 1.1 | 14.1 | -3.1 | -8.1 | 1.6 | 10.3 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 964 | 1386 | 1008 | 1232 | 1552 | 1459 | 1538 | 1702 | 2015 | 1687 | 1870 | 1988 |
| Other Income | 4 | 7 | 7 | 6 | 14 | 14 | 8 | 8 | 8 | 14 | 17 | 13 |
| Total Income | 968 | 1393 | 1015 | 1238 | 1566 | 1473 | 1546 | 1710 | 2023 | 1701 | 1887 | 2000 |
| Total Expenditure | 920 | 1286 | 940 | 1128 | 1420 | 1356 | 1381 | 1569 | 1868 | 1553 | 1767 | 1861 |
| Operating Profit | 48 | 107 | 74 | 110 | 146 | 117 | 166 | 141 | 155 | 148 | 120 | 139 |
| Interest | 84 | 84 | 80 | 88 | 90 | 69 | 72 | 60 | 73 | 76 | 72 | 48 |
| Depreciation | 47 | 44 | 50 | 49 | 50 | 45 | 47 | 48 | 50 | 60 | 50 | 55 |
| Exceptional Income / Expenses | 0 | 0 | -10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -32 |
| Profit Before Tax | -83 | -20 | -66 | -27 | 6 | 3 | 46 | 32 | 32 | 12 | -2 | 4 |
| Provision for Tax | -5 | -4 | -22 | -8 | 1 | -1 | 19 | 13 | 12 | 0 | 22 | 1 |
| Profit After Tax | -78 | -16 | -45 | -19 | 6 | 4 | 27 | 19 | 20 | 12 | -23 | 3 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | -78 | -16 | -45 | -19 | 6 | 4 | 27 | 19 | 20 | 12 | -23 | 3 |
| Adjusted Earnings Per Share | -21.7 | -4.4 | -12.1 | -5.1 | 1.4 | 1 | 6.5 | 4.6 | 4.7 | 2.9 | -4.6 | 0.7 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 11% | 3% | 5% | 7% |
| Operating Profit CAGR | -19% | -5% | 1% | 10% |
| PAT CAGR | -292% | NAN% | NAN% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -6% | NA% | NA% | NA% |
| ROE Average | -4% | 1% | 3% | -6% |
| ROCE Average | 6% | 7% | 9% | 6% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 162 | 143 | 345 | 337 | 359 | 427 | 454 | 473 | 489 | 501 | 782 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 215 | 230 | 161 | 139 | 135 | 123 | 332 | 328 | 460 | 355 | 240 |
| Other Non-Current Liabilities | 17 | 5 | 8 | -6 | -7 | -2 | 6 | 14 | 26 | 26 | 49 |
| Total Current Liabilities | 840 | 808 | 918 | 1165 | 1140 | 871 | 650 | 919 | 768 | 1110 | 884 |
| Total Liabilities | 1234 | 1186 | 1432 | 1635 | 1627 | 1419 | 1442 | 1734 | 1744 | 1992 | 1955 |
| Fixed Assets | 460 | 468 | 691 | 745 | 695 | 735 | 708 | 667 | 866 | 850 | 862 |
| Other Non-Current Assets | 69 | 52 | 94 | 21 | 86 | 39 | 41 | 87 | 53 | 65 | 69 |
| Total Current Assets | 706 | 666 | 647 | 869 | 846 | 644 | 693 | 979 | 824 | 1077 | 1023 |
| Total Assets | 1234 | 1186 | 1432 | 1635 | 1627 | 1419 | 1442 | 1734 | 1744 | 1992 | 1955 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 9 | 18 | 12 | 6 | 4 | 5 | 5 | 7 | 10 | 21 | 11 |
| Cash Flow from Operating Activities | -69 | 177 | 30 | 63 | 287 | 250 | 130 | 45 | 197 | 185 | 6 |
| Cash Flow from Investing Activities | -51 | -27 | -92 | -28 | -55 | -23 | -7 | -48 | -214 | -44 | -69 |
| Cash Flow from Financing Activities | 128 | -156 | 56 | -36 | -231 | -226 | -121 | 6 | 28 | -151 | 64 |
| Net Cash Inflow / Outflow | 9 | -6 | -6 | -2 | 1 | 1 | 2 | 3 | 11 | -10 | 1 |
| Closing Cash & Cash Equivalent | 18 | 12 | 6 | 4 | 5 | 6 | 7 | 10 | 21 | 11 | 12 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | -21.73 | -4.45 | -12.1 | -5.07 | 1.44 | 0.97 | 6.47 | 4.55 | 4.68 | 2.93 | -4.58 |
| CEPS(Rs) | -8.54 | 7.75 | 1.42 | 7.91 | 14.44 | 11.69 | 17.71 | 16 | 16.62 | 17.22 | 5.21 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 45.35 | 40.12 | 93.42 | 89.64 | 93.5 | 101.84 | 108.22 | 112.77 | 116.69 | 119.37 | 152.8 |
| Core EBITDA Margin(%) | 4.39 | 6.96 | 6.34 | 8.33 | 8.51 | 7.08 | 10.25 | 7.81 | 7.26 | 7.92 | 5.54 |
| EBIT Margin(%) | 0.09 | 4.39 | 1.32 | 4.92 | 6.2 | 4.94 | 7.72 | 5.43 | 5.19 | 5.22 | 3.76 |
| Pre Tax Margin(%) | -8.34 | -1.4 | -6.21 | -2.17 | 0.41 | 0.23 | 3.01 | 1.88 | 1.58 | 0.74 | -0.08 |
| PAT Margin (%) | -7.79 | -1.1 | -4.19 | -1.53 | 0.36 | 0.28 | 1.77 | 1.12 | 0.97 | 0.73 | -1.25 |
| Cash Profit Margin (%) | -3.06 | 1.92 | 0.49 | 2.39 | 3.57 | 3.36 | 4.83 | 3.94 | 3.46 | 4.28 | 1.42 |
| ROA(%) | -6.29 | -1.31 | -3.42 | -1.24 | 0.34 | 0.27 | 1.9 | 1.2 | 1.13 | 0.66 | -1.19 |
| ROE(%) | -47.91 | -10.41 | -18.3 | -5.59 | 1.59 | 1.03 | 6.16 | 4.12 | 4.08 | 2.48 | -3.65 |
| ROCE(%) | 0.08 | 6.24 | 1.27 | 4.84 | 7.91 | 6.65 | 11.7 | 8.72 | 8.96 | 7.4 | 5.79 |
| Receivable days | 26.96 | 21.2 | 26.67 | 29.48 | 33.3 | 33.68 | 34.98 | 36.65 | 33.95 | 42.4 | 32.01 |
| Inventory Days | 194.53 | 128.99 | 169.42 | 165 | 140.59 | 119.09 | 95.69 | 115.34 | 106.13 | 143.32 | 150.75 |
| Payable days | 51.94 | 46.5 | 72 | 84.46 | 116.29 | 134.45 | 128.05 | 146.72 | 128.45 | 159.71 | 152.94 |
| PER(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Price/Book(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.96 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.94 | 0.59 | 0.9 | 0.76 | 0.51 | 0.4 | 0.37 | 0.37 | 0.36 | 0.39 | 0.65 |
| EV/Core EBITDA(x) | 18.77 | 7.69 | 12.2 | 8.51 | 5.42 | 5.01 | 3.39 | 4.48 | 4.74 | 4.48 | 10.05 |
| Net Sales Growth(%) | 0 | 43.84 | -27.28 | 22.21 | 26.02 | -6 | 5.42 | 10.67 | 18.35 | -16.28 | 10.88 |
| EBIT Growth(%) | 0 | 6907.81 | -77.8 | 336.01 | 56.92 | -25.18 | 64.8 | -22.07 | 13.01 | -15.81 | -20.18 |
| PAT Growth(%) | 0 | 79.52 | -181.19 | 57.32 | 129 | -26.57 | 568.35 | -29.67 | 2.83 | -37.37 | -290.39 |
| EPS Growth(%) | 0 | 79.52 | -171.95 | 58.1 | 128.44 | -32.81 | 568.35 | -29.67 | 2.83 | -37.37 | -256.04 |
| Debt/Equity(x) | 5.57 | 5.74 | 2.63 | 2.8 | 2.21 | 1.38 | 1.23 | 1.34 | 1.5 | 1.31 | 0.63 |
| Current Ratio(x) | 0.84 | 0.82 | 0.7 | 0.75 | 0.74 | 0.74 | 1.07 | 1.07 | 1.07 | 0.97 | 1.16 |
| Quick Ratio(x) | 0.21 | 0.22 | 0.16 | 0.21 | 0.24 | 0.3 | 0.41 | 0.36 | 0.4 | 0.24 | 0.32 |
| Interest Cover(x) | 0.01 | 0.76 | 0.18 | 0.69 | 1.07 | 1.05 | 1.64 | 1.53 | 1.44 | 1.16 | 0.98 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.65 |
| # | Mar 2015 | Mar 2016 | Sep 2017 | Sep 2018 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 76.83 | 76.83 | 77.23 | 77.44 | 63.31 | 63.31 | 63.31 | 63.31 | 63.31 | 63.31 |
| FII | 0 | 0 | 0 | 0 | 1.14 | 0.97 | 0.63 | 0.6 | 0.86 | 0.98 |
| DII | 13.33 | 13.33 | 13.33 | 13.09 | 14.88 | 14.17 | 13.98 | 11.98 | 11.16 | 10.39 |
| Public | 9.84 | 9.84 | 9.44 | 9.46 | 20.67 | 21.55 | 22.08 | 24.12 | 24.67 | 25.32 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2015 | Mar 2016 | Sep 2017 | Sep 2018 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 2.75 | 2.75 | 2.85 | 2.91 | 3.24 | 3.24 | 3.24 | 3.24 | 3.24 | 3.24 |
| FII | 0 | 0 | 0 | 0 | 0.06 | 0.05 | 0.03 | 0.03 | 0.04 | 0.05 |
| DII | 0.48 | 0.48 | 0.49 | 0.49 | 0.76 | 0.73 | 0.72 | 0.61 | 0.57 | 0.53 |
| Public | 0.35 | 0.35 | 0.35 | 0.36 | 1.06 | 1.1 | 1.13 | 1.23 | 1.26 | 1.3 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3.57 | 3.57 | 3.7 | 3.76 | 5.12 | 5.12 | 5.12 | 5.12 | 5.12 | 5.12 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +11% | +3% | +5% | +7% |
| Operating Profit CAGR | -19% | -5% | +1% | +10% |
| PAT CAGR | -292% | 0% | 0% | — |
| Share Price CAGR | -6% | — | — | — |
| ROE Average | -4% | +1% | +3% | -6% |
| ROCE Average | +6% | +7% | +9% | +6% |
| # | Mar 2015 | Mar 2016 | Sep 2017 | Sep 2018 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 76.83 | 76.83 | 77.23 | 77.44 | 63.31 | 63.31 | 63.31 | 63.31 | 63.31 | 63.31 |
| FII | 0 | 0 | 0 | 0 | 1.14 | 0.97 | 0.63 | 0.6 | 0.86 | 0.98 |
| DII | 13.33 | 13.33 | 13.33 | 13.09 | 14.88 | 14.17 | 13.98 | 11.98 | 11.16 | 10.39 |
| Public | 23.17 | 23.17 | 22.77 | 22.56 | 36.69 | 36.69 | 36.69 | 36.69 | 36.69 | 36.69 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2015 | Mar 2016 | Sep 2017 | Sep 2018 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 2.75 | 2.75 | 2.85 | 2.91 | 3.24 | 3.24 | 3.24 | 3.24 | 3.24 | 3.24 |
| FII | 0 | 0 | 0 | 0 | 0.06 | 0.05 | 0.03 | 0.03 | 0.04 | 0.05 |
| DII | 0.48 | 0.48 | 0.49 | 0.49 | 0.76 | 0.73 | 0.72 | 0.61 | 0.57 | 0.53 |
| Public | 0.83 | 0.83 | 0.84 | 0.85 | 1.88 | 1.88 | 1.88 | 1.88 | 1.88 | 1.88 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3.57 | 3.57 | 3.7 | 3.76 | 5.12 | 5.12 | 5.12 | 5.12 | 5.12 | 5.12 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.